Report summary

Harvard University Department of Biological Chemistry and Molecular Pharmacology in 2024-2026 reads as a 37-PI network with 13 internal PI collaborations. The research center of gravity is Biochemistry, Genetics and Molecular Biology as the leading field (48% of slots across 34 PIs; 34 labels), Molecular Biology as the leading subfield (32% of slots across 28 PIs; 28 labels), and PI3K/AKT/mTOR signaling in cancer as the leading topic (4% of slots across 4 PIs; 4 labels). That is of concern for a 37-PI roster; the strongest pairings may be carrying much of the visible collaboration. The most prominent PIs by weighted works are Kevin Struhl (7.1 weighted works; Genomics and Chromatin Dynamics, RNA Research and Splicing). The strongest pairings are William M. Shih and Yang C. Zeng (2 shared works, weight 1.6). The strongest breakdown groups are group 1 with 8 PIs, 7 internal connections, weight 4.6, around Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, led by Andrew C. Kruse, Lyn H. Jones, Michael J. Eck.